Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies

Healthcare Spending Expected To Surge In Coming Years

June 2007 | Industry News

Healthcare expenditure in the Gulf Co-operation Council (GCC) is expected to reach US$60bn by 2025, according to a long-term forecast released by McKinsey. This is in line with

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
GCC Looking To Expand Its Horizons

Companies Key growth drivers are causing an upswing in foreign direct investment (FDI) in the pharmaceutical industry in the GCC. According to recently released figures from the United Nations Conference on Trade...
March 2007
M&A Strong Last Year

Companies It was an interesting year for M&A in 2006, with the total value of deals rising around 25% to US$3.6bn, as pharmaceutical companies around the world increasingly jostled for position. However, the...
January 2007
IMF Criticises MENA Business Environment

Companies The International Monetary Fund (IMF) has criticised countries in the Middle East and North Africa (MENA) region for having institutional weaknesses that deter foreign direct investment (FDI). These...
January 2007
WHO Urges Crackdown On Medicines Corruption

Companies The World Health Organisation has launched an initiative to encourage good governance in medicines procurement in developing countries. Details are sketchy, but the organisation hopes to strengthen regulatory...
November 2006
WHO Warning On 'Single Drug' Malaria Therapies

Companies The World Health Organisation (WHO) has called on a number of drug firms in the world to stop selling artemisinin-based, "single drug" malaria treatments to Africa, amid concerns that efficacy levels...
January 2006
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS